within Pharmacolibrary.Drugs.ATC.A;

model A05AX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 1.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A05AX01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Piprozolin is a choleretic agent formerly used to stimulate bile secretion in the treatment of liver or biliary tract disorders. It is classified under ATC code A05AX01. Piprozolin is not widely used or approved today and is mainly of historical or research interest.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies or parameter data on piprozolin could be found in the available literature. The following parameters are hypothetical estimates based on typical choleretic small molecule oral drugs in adults.</p><h4>References</h4><ol><li><p>Vollmer, KO, &amp; Koss, FW (1972). [The pharmacokinetics and metabolism of a new choleretic, 3-ethyl-4-oxo-5-piperidino- 2, -thiazolidineacetic acid ethyl ester (Piprozolin) after enteral administration in the rat]. <i>Archives internationales de pharmacodynamie et de therapie</i> 198(2) 312–332. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/5054739/&quot;>https://pubmed.ncbi.nlm.nih.gov/5054739</a></p></li><li><p>Gladigau, V, &amp; Ehret, I (1977). [Metabolism and pharmacokinetics of piprozoline in rat, dog and man. 3rd communication: Determination of piprozoline and metabolite I in plasma and urine (author&#x27;s transl)]. <i>Arzneimittel-Forschung</i> 27(2b) 512–516. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/577414/&quot;>https://pubmed.ncbi.nlm.nih.gov/577414</a></p></li><li><p>Vollmer, KO, et al., &amp; Schauerte, E (1977). [Metabolism and pharmacokinetics of piprozoline in the rat, dog and man. 1. Studies with the radioactively-labeled substance]. <i>Arzneimittel-Forschung</i> 27(2b) 502–508. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/577412/&quot;>https://pubmed.ncbi.nlm.nih.gov/577412</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A05AX01;
